Insider · CIK 0001400564

Lannum Coleman N III

Reports to the SEC for 2 companies · MANSFIELD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001400564

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-04	Keenova Therapeutics plcF Tax Payment	Sr. VP Investor Strategy & IRO	FTax Payment	−518 sh	$23.40	−$12.1K	32,325
2018-01-03	Keenova Therapeutics plcF Tax Payment	Sr. VP Investor Strategy & IRO	FTax Payment	−412 sh	$23.51	−$9,686.12	32,843
2017-06-09	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+1,550 sh	$39.89	+$61.8K	33,005
2017-06-09	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+1,400 sh	$39.77	+$55.7K	3,000
2017-06-05	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+500 sh	$39.33	+$19.7K	31,455
2017-06-02	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+1,350 sh	$42.89	+$57.9K	30,955
2017-05-12	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+1,968 sh	$46.20	+$90.9K	29,605
2017-01-03	Keenova Therapeutics plcA Award	Sr. VP Investor Strategy & IRO	AAward	+3,142 sh	—	—	26,410
2017-01-03	Keenova Therapeutics plcA Award	Sr. VP Investor Strategy & IRO	AAward	+902 sh	—	—	27,312
2017-01-03	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	Sr. VP Investor Strategy & IRO	AAward	+8,824 sh	—	—	8,824
2016-08-29	Keenova Therapeutics plcA Award	Sr. VP Investor Strategy & IRO	AAward	+2,359 sh	—	—	22,928
2016-08-29	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	Sr. VP Investor Strategy & IRO	AAward	+7,020 sh	—	—	7,020
2016-03-04	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+2,600 sh	$62.63	+$163K	20,556
2016-02-12	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+600 sh	$59.66	+$35.8K	17,940
2016-02-10	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+600 sh	$62.61	+$37.6K	17,340
2016-02-10	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+700 sh	$62.55	+$43.8K	1,600
2016-02-08	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+800 sh	$66.37	+$53.1K	16,740
2016-01-04	Keenova Therapeutics plcA Award	Sr. VP Investor Strategy & IRO	AAward	+2,545 sh	—	—	15,905
2016-01-04	Keenova Therapeutics plcA Award	Sr. VP Investor Strategy & IRO	AAward	+2,094 sh	—	—	13,360
2016-01-04	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	Sr. VP Investor Strategy & IRO	AAward	+6,842 sh	—	—	6,842
2015-12-22	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+500 sh	$72.50	+$36.3K	11,266
2015-12-03	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+500 sh	$73.17	+$36.6K	10,766
2015-12-01	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+200 sh	$68.35	+$13.7K	10,186
2015-11-27	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+800 sh	$66.87	+$53.5K	9,986
2015-11-27	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+400 sh	$66.84	+$26.7K	900
2015-11-24	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+300 sh	$65.04	+$19.5K	9,186
2015-11-10	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+300 sh	$57.53	+$17.3K	8,886
2015-10-06	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+300 sh	$63.54	+$19.1K	8,388
2015-09-01	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+200 sh	$84.74	+$16.9K	8,061
2015-08-25	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+500 sh	$80.85	+$40.4K	7,861
2015-08-21	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+1,900 sh	$88.49	+$168K	7,361
2015-08-21	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+400 sh	$88.77	+$35.5K	500
2015-08-21	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+45 sh	$87.88	+$3,954.6	75
2015-08-21	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+15 sh	$87.77	+$1,316.55	45
2015-08-21	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+15 sh	$87.77	+$1,316.55	45
2015-08-07	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+200 sh	$98.50	+$19.7K	5,390
2015-06-04	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+1,000 sh	$126.20	+$126K	4,890
2015-06-04	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+300 sh	$127.11	+$38.1K	5,190
2015-05-22	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+660 sh	$127.69	+$84.3K	3,890
2015-05-08	Keenova Therapeutics plcP Purchase	Sr. VP Investor Strategy & IRO	PPurchase	+340 sh	$122.52	+$41.7K	3,230
2015-04-01	Keenova Therapeutics plcA Award	Sr. VP Investor Strategy & IRO	AAward	+1,524 sh	—	—	2,845
2015-04-01	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Sr. VP Investor Strategy & IRO	AAward	+5,272 sh	—	—	5,272
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−662 sh	—	—	35,038
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−35K sh	—	—	0
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−350 sh	—	—	0
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−255 sh	—	—	0
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−255 sh	—	—	0
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−255 sh	—	—	0
2015-01-26	Covidien plcD Disposition to Issuer	Vice President	DDisposition to Issuer	−3,512 sh	—	—	0
2015-01-26	Covidien plcStock Option (Right to Buy)D Disposition to Issuer	Vice President	DDisposition to Issuer	−200 sh	—	—	0

Recent filings

Accepted (ET)
Jan 54
Lannum Coleman N III0000950138-18-000043
SEC(opens sec.gov)
Jun 124
Mallinckrodt plc0000950138-17-000484
SEC(opens sec.gov)
Jun 74
Mallinckrodt plc0000950138-17-000464
SEC(opens sec.gov)
Jun 54
Mallinckrodt plc0000950138-17-000454
SEC(opens sec.gov)
May 154
Mallinckrodt plc0000950138-17-000411
SEC(opens sec.gov)
Jan 44
Mallinckrodt plc0000950138-17-000026
SEC(opens sec.gov)
Aug 304
Mallinckrodt plc0000950138-16-001280
SEC(opens sec.gov)
Mar 84
Mallinckrodt plc0001445064-16-000212
SEC(opens sec.gov)
Feb 164
Mallinckrodt plc0001445064-16-000207
SEC(opens sec.gov)
Feb 114
Mallinckrodt plc0001445064-16-000205
SEC(opens sec.gov)
Feb 94
Mallinckrodt plc0001445064-16-000201
SEC(opens sec.gov)
Jan 64
Mallinckrodt plc0001445064-16-000197
SEC(opens sec.gov)
Jan 54
Mallinckrodt plc0001445064-16-000186
SEC(opens sec.gov)

Companies

Address

C/O COVIDIEN 15 HAMPSHIRE STREET

MANSFIELD, MA, 02048